Your browser doesn't support javascript.
loading
Forkhead domain mutations in FOXA1 drive prostate cancer progression.
Gao, Shuai; Chen, Sujun; Han, Dong; Barrett, David; Han, Wanting; Ahmed, Musaddeque; Patalano, Susan; Macoska, Jill A; He, Housheng Hansen; Cai, Changmeng.
Afiliação
  • Gao S; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.
  • Chen S; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Han D; Princess Margaret Cancer Center/University Health Network, Toronto, ON, M5G1L7, Canada.
  • Barrett D; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.
  • Han W; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.
  • Ahmed M; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.
  • Patalano S; Princess Margaret Cancer Center/University Health Network, Toronto, ON, M5G1L7, Canada.
  • Macoska JA; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.
  • He HH; Center for Personalized Cancer Therapy, University of Massachusetts Boston, Boston, MA, 02125, USA.
  • Cai C; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. hansenhe@uhnresearch.ca.
Cell Res ; 29(9): 770-772, 2019 Sep.
Article em En | MEDLINE | ID: mdl-31324883
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fator 3-alfa Nuclear de Hepatócito Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fator 3-alfa Nuclear de Hepatócito Idioma: En Ano de publicação: 2019 Tipo de documento: Article